Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells - PubMed (original) (raw)
- PMID: 3485879
- DOI: 10.1007/BF00688305
Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells
G M Lauro et al. Acta Neuropathol. 1986.
Abstract
Cultured human glioma cells were found to produce soluble factors that can modulate the in vitro proliferative response of purified T lymphocytes stimulated by phytohemagglutinin (PHA). Neoplastic tissue was removed during surgery for brain glial tumors and cultured in vitro. The glial nature of the neoplastic cells was verified by means of anti-glial fibrillary acidic protein immunohistochemical staining. Serum-free supernatants from these cultures proved capable of suppressing in vitro proliferation of PHA-stimulated T lymphocytes. Suppression was reduced when indomethacin or aspirin was added to the culture medium. Thin-layer chromatography revealed the presence of prostaglandins and other arachidonic acid derivatives in the supernatants. The radioimmunoassay used to quantify the prostaglandin E2 (PGE2) in the supernatants showed detectable amounts of PGE2, which disappeared after the cultures had been treated with anti-inflammatory drugs. These data support the hypothesis that tumoral glial cells can play a role in the host immune response in the central nervous system, namely by producing soluble factors.
Similar articles
- The effects of prostaglandins on the proliferation of cultured human T lymphocytes.
Maca RD. Maca RD. Immunopharmacology. 1983 Dec;6(4):267-77. doi: 10.1016/0162-3109(83)90033-4. Immunopharmacology. 1983. PMID: 6317610 - Suppressive effect of thymosin fraction 5 on proliferation of cultured human T lymphocytes.
Wolf RE, Maca RD. Wolf RE, et al. Immunopharmacology. 1986 Dec;12(3):233-40. doi: 10.1016/0162-3109(86)90007-x. Immunopharmacology. 1986. PMID: 3493229 - Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients.
Balch CM, Dougherty PA, Cloud GA, Tilden AB. Balch CM, et al. Surgery. 1984 Jan;95(1):71-7. Surgery. 1984. PMID: 6229053 - The pharmacologic regulation of interleukin-1 production: the role of prostaglandins.
Otterness IG, Bliven ML, Eskra JD, Reinke M, Hanson DC. Otterness IG, et al. Cell Immunol. 1988 Jul;114(2):385-97. doi: 10.1016/0008-8749(88)90330-9. Cell Immunol. 1988. PMID: 2968844 - The effects of indomethacin on T lymphocyte stimulation.
Kingston AE, Ivanyi J, Kay JE. Kingston AE, et al. Immunol Lett. 1984;8(6):301-5. doi: 10.1016/0165-2478(84)90014-2. Immunol Lett. 1984. PMID: 6335488
Cited by
- A water soluble CoQ10 formulation improves intracellular distribution and promotes mitochondrial respiration in cultured cells.
Bergamini C, Moruzzi N, Sblendido A, Lenaz G, Fato R. Bergamini C, et al. PLoS One. 2012;7(3):e33712. doi: 10.1371/journal.pone.0033712. Epub 2012 Mar 14. PLoS One. 2012. PMID: 22432044 Free PMC article. - Vaccine-based immunotherapeutic approaches to gliomas and beyond.
Weller M, Roth P, Preusser M, Wick W, Reardon DA, Platten M, Sampson JH. Weller M, et al. Nat Rev Neurol. 2017 Jun;13(6):363-374. doi: 10.1038/nrneurol.2017.64. Epub 2017 May 12. Nat Rev Neurol. 2017. PMID: 28497804 Review. - Role of mitochondrial complex I and protective effect of CoQ10 supplementation in propofol induced cytotoxicity.
Bergamini C, Moruzzi N, Volta F, Faccioli L, Gerdes J, Mondardini MC, Fato R. Bergamini C, et al. J Bioenerg Biomembr. 2016 Aug;48(4):413-23. doi: 10.1007/s10863-016-9673-9. Epub 2016 Aug 15. J Bioenerg Biomembr. 2016. PMID: 27525823 - In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes.
Sawamura Y, Diserens AC, de Tribolet N. Sawamura Y, et al. J Neurooncol. 1990 Oct;9(2):125-30. doi: 10.1007/BF02427832. J Neurooncol. 1990. PMID: 2175768 - Synthesis and secretion of alpha 2-macroglobulin by human glioma established cell lines.
Businaro R, Fabrizi C, Fumagalli L, Lauro GM. Businaro R, et al. Exp Brain Res. 1992;88(1):213-8. doi: 10.1007/BF02259144. Exp Brain Res. 1992. PMID: 1371755
References
- Eur J Immunol. 1983 Aug;13(8):685-9 - PubMed
- Eur J Immunol. 1982 Apr;12(4):354-7 - PubMed
- Methods Enzymol. 1982;86:477-93 - PubMed
- Immunology. 1983 Apr;48(4):713-22 - PubMed
- J Neurol Sci. 1976 Nov;30(1):55-64 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials